Appraising Evidence
| Course home | Appraising information | Keeping up | Informatics principles | Patients | Searching | Wiki help |
Critical appraisal cheat sheet
('Blue card')
Converting units
Converting to/from Systeme International d'Unites (from MGH Case Records in the NEJM)
Glossaries
- UTHSCSA
- Clinical Evidence (most detailed)
- Oxford-Centre for Evidence Based Medicine
- ACP Journal Club
- On UTHSCSA network: http://www.acpjc.org/shared/glossary.htm
- Not on UTHSCSA network: EZProxy (PIN required)
Levels of Evidence
- Table from Oxford-Centre for Evidence Based Medicine
Beyond levels of evidence: more detail for specific study designs
Diagnosis
More information:
Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703-7. PMID: 8309035
PubMed:
Abstract - Related articlesFulltext options:
EBSCO - OVID - Centre for Health Evidence (free access)
Summary of Bayes theory:
- Rarely is a test perfect with both sensitivity & specificity equal 100%
- If a test result is unexpected, it may be incorrect
- SPPIN and SNNOUT (more from CEBM )
- For a test to be useful in isolation, needs:
- sn or sp>90 to 95%
- or -
LR+ > 5-10 or LR- < 0.2 to 0.1 (Likelihood ratios) - SPPIN - highly SPecific test, if Positive, helps rule IN
- SNNOUT - highly SNecific test, if Negative, helps rule OUT
- sn or sp>90 to 95%
- For a test to be useful in isolation, needs:
Treatment
More information:
Wen L, Badgett R, Cornell J. Number needed to treat: a descriptor for weighing therapeutic options. Am J Health Syst Pharm 2005;62:2031-6. PMID: 16174840
PubMed:
Abstract - Related articlesFulltext options:
JAMA - CrossRef - DOI - EBSCO - OVID
Use NNT:
- Probably better for understanding complex information
Limitations of NNT:
- Difficult math
- Need to specify length of treatment
- Does not generalize across different risks of outcome
Evidence tables
Organize your evidence - sample evidence table
Creating an evidence table may help your organize your thinking and help listeners follow your presentation. Below is a suggested format. We may only discuss 1-2 of your articles in class, but preparing the evidence table will help you identify which articles best support your conclusion.| Study, year | Patients | Intervention | Outcome measured | Results | Comments |
|---|---|---|---|---|---|
Spring, 2008 (CORTICUS) RCT |
|
50 mg of intravenous hydrocortisone q 6 hrs for 5 days |
mortality |
Overall: |
Steroids did not help. However, these patients were less sick than those in the Annane study (note difference in control group mortality). |
Annane, 2002 RCT |
76% with adrenal insuff (<9mcg cortisol increase after corticotropin test). |
hydrocortisone (50 mg q 6 hrs) & fludrocortisone (50 mcg qd) |
mortality | Overall: steroid group 55% placebo 61% (P=.09) Adrenal normal: steroid group 61% placebo 53% (P=.02) Adrenal insufficient: steroid group 53% placebo 63% (P=.02) |
Steroids (with fludrocortisone) helped those with adrenal insufficiency. First study with sufficient power.
Cotreated with fludrocortisone. |
Briegel, 1999 RCT |
40 pts | hydrocortisone 100 mg bolus, 0.18 mg/kg/hr (100 kg patient would receive 432 mg/d) |
mortality shock reversal |
Mortality: steroids: 20% placebo 30%(insig) Shock reversal: steroids:90% placebo: 80%(insig) |
Small size limits power |
Bollaert, 1998 RCT |
41 patients requiring pressors >48 hrs. 29% were adrenal insufficient (<6mcg cortisol increase after corticotropin test) |
hydrocortisone 100 mg tid x5d | mortality | Overall: steroids: 32% placebo: 63% (insig) Adrenal normal (n=29): steroids 33% placebo 64% Adrenal insufficient (n=12): steroids 25% placebo 63% |
Introduced role of corticotropin testing - which did not predict response
to steroids. |
Cronin,
1995 Systematic review of RCTs |
730 patients with septic shock in 6 studies |
varying regimens | mortality | RR=1.07 (95% CI 0.91, 1.26) | Much heterogeneity |
Lefering,
1995 Systematic review of RCTs |
1329 patients in 10 studies |
varying regimens | mortality | ARR=-0.2% (CI: -9.2, 8.8) | Much heterogeneity No differences between low - vs. high-dose or type of corticosteroid. The Gram-negative group demonstrated better outcome (-5.6% vs. 1.8% for gram positive). |
Conclusion in this example:
The best evidence suggests that in this clinical controversy, the risk of death
is reduced, but only in patients with relative adrenal insufficiency and if
steroids are combined with a mineralocorticoid.
Calculators
- Online calculators:
- Generic epi Calculator (UTHSCSA)
- Center for Evidence-based medicine (click 'EBM tool box')
- Dx calculator
- Dx nomogram
- Palm OS application available at either:
- Pocket PC Versions:
